Page 77 - Haematologica Vol. 109 - July 2024

ARTICLE - Familial germline pathogenic alleles and hematologic malignancies Q. Feng et al.
leukemia and T-cell prolymphocytic leukemia. Leuk Lymphoma.
202263(4):865-875.
30. Bea S, Valdes-Mas R, Navarro A, et al. Landscape of somatic
mutations and clonal evolution in mantle cell lymphoma. Proc
Natl Acad Sci U S A. 2013;110(45):18250-18255.
31. Lin L, Cai J, Tan Z, et al. Mutant IDH1 enhances temozolomide
sensitivity via regulation of the ATM/CHK2 pathway in glioma.
Cancer Res Treat. 2021;53(2):367-377.
32. Genestie C, Blanc-Durand F, Auguste A, et al. Clinical utility of
SMARCA4 testing by immunohistochemistry in rare ovarian
tumours. Br J Cancer. 2020;122(4):564-568.
33. Dong A, Lu Y, Lu B. Genomic/epigenomic alterations in ovarian
carcinoma: translational insight into clinical practice. J Cancer.
2016;7(11):1441-1451.
34. Lv J, Qiu M, Xia W, et al. High expression of long non-coding
RNA SBF2-AS1 promotes proliferation in non-small cell lung
cancer. J Exp Clin Cancer Res. 2016;35:75.
35. Chen G, Gu Y, Han P, et al. Long noncoding RNA SBF2-AS1
promotes colorectal cancer proliferation and invasion by inhibiting miR-619-5p activity and facilitating HDAC3 expression. J Cell Physiol. 2019;234(10):18688-18696.
36. Chen R, Xia W, Wang X, et al. Upregulated long non-coding RNA SBF2-AS1 promotes proliferation in esophageal squamous cell carcinoma. Oncol Lett. 2018;15(4):5071-5080.
37. Gao F, Feng J, Yao H, et al. LncRNA SBF2-AS1 promotes the progression of cervical cancer by regulating miR-361-5p/FOXM1 axis. Artif Cells Nanomed Biotechnol. 2019;47(1):776-782.
38. He M, Feng L, Qi L, Rao M, Zhu Y. Long noncoding RNASBF2-AS1 promotes gastric cancer progression via regulating miR-545/ EMS1 axis. Biomed Res Int. 2020;2020:6590303.
39. Hua YQ, Zhu YD, Xie GQ, et al. Long non-coding SBF2-AS1 acting as a competing endogenous RNA to sponge microRNA-142-3p to participate in gemcitabine resistance in pancreatic cancer via upregulating TWF1. Aging (Albany NY). 2019;11(20):8860-8878.
40. Li Y, Liu G, Li X, et al. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway. Biochem Biophys Res Commun.
2018;503(4):2826-2832.
41. Tian YJ, Wang YH, Xiao AJ, et al. Long noncoding RNA SBF2-AS1
acts as a ceRNA to modulate cell proliferation via binding with miR-188-5p in acute myeloid leukemia. Artif Cells Nanomed Biotechnol. 2019;47(1):1730-1737.
42. Xia W, Liu Y, Cheng T, et al. Down-regulated lncRNA SBF2-AS1 inhibits tumorigenesis and progression of breast cancer by sponging microRNA-143 and repressing RRS1. J Exp Clin Cancer Res. 2020;39(1):18.
43. Yu H, Zheng J, Liu X, et al. Transcription factor NFAT5 promotes glioblastoma cell-driven angiogenesis via SBF2-AS1/miR-338- 3p-mediated EGFL7 expression change. Front Mol Neurosci. 2017;10:301.
44. Zha W, Li X, Tie X, et al. The molecular mechanisms of the long noncoding RNA SBF2-AS1 in regulating the proliferation of oesophageal squamous cell carcinoma. Sci Rep. 2021;11(1):805.
45. Zhang Q, Pan X, You D. Overexpression of long non-coding RNA SBF2-AS1 promotes cell progression in esophageal squamous cell carcinoma (ESCC) by repressing miR-494 to up-regulate PFN2 expression. Biol Open. 2020;bio.048793.
46. Zhang Z, Yin J, Lu C, et al. Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma. J Exp Clin Cancer Res. 2019;38(1):166.
47. Caruso R, Warner N, Inohara N, Nunez G. NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity. 2014;41(6):898-908.
48. Branquinho D, Freire P, Sofia C. NOD2 mutations and colorectal cancer - where do we stand? World J Gastrointest Surg. 2016;8(4):284-293.
49. Ross KA. Coherent somatic mutation in autoimmune disease. PLoS One. 2014;9(7):e101093.
50. Gara SK, Jia L, Merino MJ, et al. Germline HABP2 mutation causing familial nonmedullary thyroid cancer. N Engl J Med. 2015;373(5):448-455.
51. Rio-Machin A, Vulliamy T, Hug N, et al. The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants. Nat Commun. 2020;11(1):1044.
Haematologica | 109 July 2024
2091